Angela Steinauer’s lab focuses on the engineering of non-viral, protein-based nanocarriers for targeted RNA delivery. Inspired by viral nucleic acid-protein assemblies, her group adopts a bottom-up approach and utilizes protein design, biomolecular engineering, and directed evolution to construct carriers with tailored functionalities.
Research in the Milton Group seeks to couple metalloenzymes that catalyze important reductive reactions to electrodes, in order to study their electron transfer/catalytic mechanisms and ultimately aid the development of new biotechnologies (and bio-inspired technologies).
The Schuhmacher Lab is interested in answering outstanding questions in membrane biology. Their chemical biology approach opens the door to investigate the so far mostly invisible and thus secret work of lipids. In particular, they would like to understand the biological role of lipid diversity and their impact on signaling processes.
Pioneering in the development of novel (bio)chemical methods to map cellular protein-lipid interaction networks, the Gavin group has a strong research interest in the study of lipid metabolism and the regulation of cellular membranes homeostasis, with a special focus on the machinery involved in the creation and maintenance of lipid gradients in eukaryotic cells, and the study of mechanisms by which lipid signatures are sensed and “read” by effector proteins.
Pablo Rivera-Fuentes lab, draws from the fields of organic synthesis, molecular biology, protein engineering, single-molecule imaging, and artificial intelligence to develop small-molecule and protein tools to study the subcellular compartementalization of biological processes. Current research lines in our lab include the characterization of the redox states of mammalian organelles, the creation of chemigenetic markers and sensors for in vivo imaging, and the development of single-molecule peptide and protein identification technologies.
Sascha Hoogendoorn lab aims to study and perturb cellular signalling, with a particular interest in the primary cilium and the Hedgehog signalling pathway. Her research combines organic chemistry with cell biology and CRISPR/Cas9-based gene editing to develop molecules that enable further dissection and manipulation of ciliary signalling.
The principal focus of the research conducted by the Waser group is the development and application of new catalytic methods for the synthesis of bioactive compounds. His lab harnesses the power of modern catalysis to promote C-C or C-X bond formation, allowing for a rapid and efficient enhancement in molecular complexity.
The Academic Chemical Screening platform of Switzerland (ACCESS), led by Gerardo Turcatti, provides the scientific community with chemical diversity, screening facilities, medicinal chemistry and know-how in chemical genetics.
Aurélien Roux main research interest explores the common biological and mechanical mechanisms by which surfaces formed by cell monolayers or lipid bilayers are deformed during physiological processes such as membrane traffic, endocytosis, cell-division, cell migration and others.
The ultimate goal of Christian Heinis lab is the development of therapeutics by developing peptide macrocycles for potential therapeutic application using phase based strategy and biological and chemical tools. His lab currently develops potent antagonists to a range of disease targets, following medical indications in which bicyclic peptides promise advantages over small molecules and monoclonal antibodies.